Related Experiment Videos
Antigenic determinants in type 1 diabetes mellitus. Review article
1Clinica Medica 2-Endocrinologia, University of Rome La Sapienza, Italy.
Summary
Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, targeting multiple autoantigens. Autoantibodies against these targets are key predictive markers for disease development.
Area of Science:
- Immunology
- Endocrinology
- Genetics
Background:
- Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by the destruction of insulin-producing pancreatic beta cells in genetically susceptible individuals.
- Unlike other autoimmune disorders, T1DM involves an autoimmune response to multiple autoantigens.
- Autoantibodies and autoreactive T lymphocytes targeting islet cell molecules are present before and during disease onset in humans and animal models.
Purpose of the Study:
- To review available data on antigenic determinants in type 1 diabetes.
- To highlight autoantibodies as predictive markers for T1DM development.
Main Methods:
- Literature review of studies on type 1 diabetes autoimmunity.
- Analysis of data on autoantigens recognized by autoantibodies and T lymphocytes.
- Focus on autoantibodies as predictive markers.
Main Results:
- Type 1 diabetes is associated with autoimmunity against a variety of autoantigens.
- Autoantibodies and autoreactive T lymphocytes are detectable before disease onset.
- Autoantibodies are significant predictive markers for T1DM in screening studies.
Conclusions:
- The autoimmune response in type 1 diabetes targets multiple autoantigens.
- Autoantibodies are crucial for predicting future disease development in type 1 diabetes.